Neuralink for Device Control
If you're interested in participating in our clinical trials for device control, join our Patient Registry.
PRIME
ClinicalTrials.gov ID: NCT06429735
What is the PRIME Study investigating?
The N1 Implant, which is an investigational brain-computer interface designed to help people with paralysis control external devices using only their thoughts.
Has anyone used the N1 Implant before?
Yes. The first participant received their Neuralink implant in January 2024.
Since then, multiple ALS and spinal cord injury participants have received the N1 Implant.
Who may be eligible?
We are looking for individuals who:
- Have limited or no ability to use both hands due to:
- Spinal cord injury, or
- Amyotrophic lateral sclerosis (ALS)
- Are at least 22 years old
- Have a consistent and reliable caregiver
- Are permanent residents of the United States
CONVOY
ClinicalTrials.gov ID: NCT06710626
What is the CONVOY Study investigating?
The use of the N1 Implant to control an assistive robotic arm.
Who may be eligible?
Participants from the PRIME Study may be eligible.
Study Sites
- Barrow Neurological Institute
- University of Miami
If you or someone you love is interested in learning more about Neuralink’s clinical trials, we encourage you to join our Patient Registry.
How it works
When trying to move a part of the body, the brain sends signals to the appropriate body part to execute the intended movement. Some conditions and injuries of the brain and spinal cord, however, prevent these signals from reaching the appropriate body part, causing paralysis.
Brain-computer interfaces (BCIs) are devices that directly record these brain signals and decode them into useful information to control external devices.
At Neuralink, we are developing an implanted BCI to enable people with paralysis to control devices such as computers, smartphones, and robotic arms to help restore independence.